Predicting liver metastasis of gastrointestinal tract cancer by diffusion-weighted imaging of apparent diffusion coefficient values
- PMID: 26973399
- PMCID: PMC4779926
- DOI: 10.3748/wjg.v22.i10.3031
Predicting liver metastasis of gastrointestinal tract cancer by diffusion-weighted imaging of apparent diffusion coefficient values
Abstract
Aim: To determine if efficacy of chemotherapy on liver metastasis of gastrointestinal tract cancer can be predicted by apparent diffusion coefficient (ADC) values of diffusion-weighted imaging (DWI).
Methods: In total, 86 patients with liver metastasis of gastrointestinal tract cancer (156 metastatic lesions) diagnosed in our hospital were included in this study. The maximum diameters of these tumors were compared with each other before treatment, 2 wk after treatment, and 12 wk after treatment. Selected patients were classified as the effective group and the ineffective group, depending on the maximum diameter of the tumor after 12 wk of treatment; and the ADC values at different treatment times between the two groups were compared. Spearman rank correlation was used to analyze the relationship between ADC value and tumor diameter. Receiver operating characteristic curve (ROC curve) was used to analyze the ADC values before treatment to predict the patient's sensitivity and specificity degree of efficacy to the chemotherapy.
Results: There was no difference in age between the two groups and in maximum tumor diameter before treatment and 2 wk after treatment. However, after 12 wk of treatment, maximum tumor diameter in the effective group was significantly lower than that in the ineffective group (P < 0.05). Before treatment, ADC values in the ineffective group were significantly higher than those in the effective group (P < 0.05). There was no difference in ADC values between the effective and ineffective groups after 2 and 12 wk of treatment. However, ADC values were significantly higher after 2 and 12 wk of treatment compared to before treatment in the effective group (P < 0.05). Spearman rank correlation analysis showed that ADC value before treatment and the reduced percentage of the maximum tumor diameter after 12 wk of treatment were negatively correlated, while the increase in the percentage of the ADC value 12 wk after treatment and the decrease in the percentage of the maximum tumor diameter were significantly positively correlated. The results of the ROC curve showed that ADC value with a chemotherapy ineffective threshold value of 1.14 × 10(-3) mm(2)/s before treatment had a sensitivity and specificity of 94.3% and 76.7%, respectively.
Conclusion: DWI ADC values can be used to predict the response of patients with liver metastasis of gastrointestinal tract cancer to chemotherapy with high sensitivity and relatively high specificity.
Keywords: Chemotherapy; Gastrointestinal tract cancer; Liver metastatic tumor; Magnetic resonance imaging.
Figures


Similar articles
-
[Value of MR diffusion-weighted imaging in diagnosis and outcome prediction for uterine cervical cancer].Zhonghua Zhong Liu Za Zhi. 2014 Feb;36(2):115-9. Zhonghua Zhong Liu Za Zhi. 2014. PMID: 24796459 Chinese.
-
Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer using diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging.Neoplasma. 2017;64(3):430-436. doi: 10.4149/neo_2017_314. Neoplasma. 2017. PMID: 28253722
-
Apparent diffusion coefficient measurements as very early predictive markers of response to chemotherapy in hepatic metastasis: a preliminary investigation of reproducibility and diagnostic value.J Magn Reson Imaging. 2014 Aug;40(2):448-56. doi: 10.1002/jmri.24359. Epub 2013 Oct 29. J Magn Reson Imaging. 2014. PMID: 24924334 Clinical Trial.
-
Antiangiogenic therapy for liver metastasis of gastrointestinal malignancies.J Hepatobiliary Pancreat Surg. 1999;6(1):1-6. doi: 10.1007/s005340050077. J Hepatobiliary Pancreat Surg. 1999. PMID: 10436231 Review.
-
Bacteriotherapy in gastrointestinal cancer.Life Sci. 2020 Aug 1;254:117754. doi: 10.1016/j.lfs.2020.117754. Epub 2020 May 7. Life Sci. 2020. PMID: 32389833 Review.
Cited by
-
A prospective randomized trial comparing microwave and radiofrequency ablation for the treatment of liver metastases using a dual ablation system ─ The Mira study.Eur J Radiol Open. 2022 Jan 28;9:100399. doi: 10.1016/j.ejro.2022.100399. eCollection 2022. Eur J Radiol Open. 2022. PMID: 35155721 Free PMC article.
-
Diagnostic performance of apparent diffusion coefficient values for the differentiation of intrahepatic cholangiocarcinoma from gastrointestinal adenocarcinoma liver metastases.Radiol Oncol. 2021 Dec 22;56(1):54-59. doi: 10.2478/raon-2021-0052. Radiol Oncol. 2021. PMID: 34957725 Free PMC article.
-
Apparent diffusion coefficient is a good marker in predicting the prognosis in colorectal cancer liver metastases: a diagnostic study.J Gastrointest Oncol. 2022 Oct;13(5):2375-2381. doi: 10.21037/jgo-22-861. J Gastrointest Oncol. 2022. PMID: 36388650 Free PMC article.
-
Diffusion weighted magnetic resonance imaging of liver: Principles, clinical applications and recent updates.World J Hepatol. 2017 Sep 18;9(26):1081-1091. doi: 10.4254/wjh.v9.i26.1081. World J Hepatol. 2017. PMID: 28989564 Free PMC article. Review.
-
Predictive Value of MRI with Serum Lectin-Reactive Alpha-Fetoprotein for Liver Cancer Recurrence after Percutaneous Radiofrequency Ablation.Evid Based Complement Alternat Med. 2022 Jul 19;2022:5132135. doi: 10.1155/2022/5132135. eCollection 2022. Evid Based Complement Alternat Med. 2022. Retraction in: Evid Based Complement Alternat Med. 2023 Jun 21;2023:9758092. doi: 10.1155/2023/9758092. PMID: 35911145 Free PMC article. Retracted.
References
-
- Schüle S, Altendorf-Hofmann A, Dittmar Y, Rauchfuß F, Settmacher U. [Incidence of non-metastatic liver lesions in tumor patients: consequences for chemotherapy and local ablative procedures] Chirurg. 2014;85:806–811. - PubMed
-
- Levic K, Bulut O, Hesselfeldt P. Transanal endoscopic microsurgery for giant polyps of the rectum. Tech Coloproctol. 2014;18:521–527. - PubMed
-
- Lambertz A, Klink CD, Röth A, Schmitz D, Pich A, Feher K, Bremus-Köbberling E, Neumann UP, Junge K. Laser-induced drug release for local tumor control--a proof of concept. J Surg Res. 2014;192:312–316. - PubMed
-
- Gourtsoyianni S, Goh V. MRI of anal cancer: assessing response to definitive chemoradiotherapy. Abdom Imaging. 2014;39:2–17. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical